NSABP Foundation Inc.
Cory Shields is a seasoned finance professional with extensive experience in financial analysis and accounting. Currently serving as a Senior Financial Analyst at NSABP Foundation Inc. since January 2021, Cory has a strong background that includes previous roles as a Financial Analyst at UPMC and various positions at Dream Center Education Holdings, LLC. Responsibilities have included managing complex accounting tasks, preparing financial statements, conducting detailed reconciliations, and providing technical support for payroll processes. Cory holds a Bachelor of Science in Business Administration with a concentration in Accounting from the University of Pittsburgh and an Associate's degree in Accounting from Community College of Allegheny County, complemented by experience as a tutor in accounting subjects.
NSABP Foundation Inc.
Partners in Cancer Research… The NSABP Foundation is a not-for-profit academic research organization with a nearly 60-year history of conducting ground-breaking research studies in breast and colorectal cancer. Our goal is to improve outcomes for cancer patients via improved therapeutic and prevention modalities. Over the past 15 years we have established full-service capabilities to conduct independently funded international research with the private sector to evaluate promising new agents and now offer a wide range of capabilities, from pre-clinical research through phase III clinical trials focused on biomarker-driven studies. In its history the NSABP has enrolled more than 110,000 women and men in clinical trials in breast and colorectal cancer. We have research sites at nearly 700 major medical centers, university hospitals, large oncology practice groups, and health maintenance organizations in the United States, Canada, and Ireland. At those sites and their satellites, about 5000 physicians, nurses, and other medical professionals conduct NSABP treatment and prevention trials. The NSABP Foundation, located at Nova Place in Pittsburgh, Pennsylvania, carries on the legacy of the National Surgical Adjuvant Breast and Bowel Project in clinical studies done in partnership with industry.